(Z)-Ethyl 2-((dimethylamino)methylene)-3-oxohexanoate, 97%, 5g

Asa de inoculación estéril, 10 μl, 3,9 mm, 40 x 25 1000 piezas

6-amino-2-(4-methylpiperazin-1-yl)pyrimidin-4(3H)-one, 250mg

(S,S)-(-)-2,2'-Isopropylidenebis(4-tert-butyl-2-oxazoline), 97.0%, 250mg

2-(Trifluoroacetoxy)pyridine, 1g

2-(5-Amino-benzoimidazol-1-yl)-ethanol; dihydrochloride, 95.0%, 250mg

3-(benzo[d][1,3]dioxol-5-yl)pyrrolidine, 95.0%, 1g

Oxazolo[5,4-c]pyridin-2(1H)-one, 95.0%, 250mg

5-(4-Methoxy-phenyl)-2 H -pyrazole-3-carboxylic acid hydrazide, 98.0%, 1g

4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenethyl)morpholine, 95.0%, 100mg

5-Methoxyquinolin-6-amine, 97%, 250mg

2,2,2-Trifluoroethylamine, 99.0%, 25g

1-tert-Butyl 4-ethyl 4-cyanopiperidine-1,4-dicarboxylate, 95.0%, 2g